Join a study of an investigational treatment for Crohn's Disease!
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
Crohn's Disease (CD) Risankizumab Ustekinumab SKYRIZI Crohn Disease Antibodies, Monoclonal
- accepting new patients
- Start Date
- Completion Date
- This clinical study may be evaluating a usage that is not currently FDA approved. Please see US Prescribing Information for approved uses. Sign up for this study
- Phase 3
- Study Type
- Last Updated